Undiagnosed Diabetes in a Dental Setting
Screening for Undiagnosed Diabetes in a Dental Setting - A New Paradigm for Dental Practice
1 other identifier
interventional
101
1 country
1
Brief Summary
In an ongoing study new dental patients are screened to determine their risk of having undiagnosed pre-diabetes or diabetes based on risk factors readily known by the patient and signs of gum disease. Investigators further seek to assess if a post-identification intervention leads to a greater likelihood of study participants identified as potentially pre-diabetic or diabetic visiting their physician regarding their screening blood test results, and to improved health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 10, 2012
CompletedFirst Posted
Study publicly available on registry
October 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedAugust 17, 2021
August 1, 2021
3.7 years
October 10, 2012
August 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of follow-up visit to physician regarding screening result
Investigators want to determine if the enhanced intervention increases the likelihood that study participants identified as potentially pre-diabetic or diabetic visit their physician to discuss the screening results of their and to receive advice from their physician, relative to participants in the standard practice group.
Baseline up to six months
Secondary Outcomes (2)
Decrease in HbA1c
Baseline up to six months
Improved periodontal measures
Baseline up to six months
Study Arms (2)
Standard practice
NO INTERVENTIONStudy patients are notified of their "diagnostic" test result within 72 hours. Those identified as potentially pre-diabetic or diabetic and randomized to the basic/control intervention, are informed that it is important to follow-up with their physician regarding their test results. They are contacted by phone once to schedule their 6-month recall visit.
Enhanced intervention
EXPERIMENTALStudy patients are notified of their "diagnostic" test result within 72 hours. Those identified as potentially pre-diabetic or diabetic and randomized to the enhanced group, receive a tailored message about their modifiable risks and are advised to see their physician regarding their test results. They are given a letter to take to their physician and receive a call at month two and then again at month four if necessary to inquire if they have followed-up with their physician and encouragement to do so, if they have not, prior to their six month follow-up study visit.
Interventions
Study patients are notified of their blood test result within 72 hours. Those identified as potentially pre-diabetic or diabetic, and randomized to the enhanced intervention arm, receive a tailored message about their modifiable risks and are advised to see their physician regarding their test results or are provided with a referral to one. They are given a letter to take to their physician that specifies the risk factors identified, the tests carried out for the patient and the exact numeric results. They receive a call at month 2 to see if they have followed up with a physician regarding their test results. If they have not seen a physician regarding their results, they are advised again to do so and reminded of their individual risk factors. At month 4 they are asked again if they have seen a physician regarding their test results. If they still have not seen a physician at this time the message is reinforced. They are contacted again by phone to schedule the 6-month recall visit.
Eligibility Criteria
You may qualify if:
- Patient who presents at the Columbia University College of Dental Medicine dental clinic
- Never been told that pre-diabetic or diabetic
- years old or older, if white
- years old or older, if non-white
- If female, not pregnant
- Not completely edentulous
- Able to undergo a periodontal examination
You may not qualify if:
- Previously told by physician that prediabetes or diabetes is present
- \< 40 years of age if non-hispanic and white, and \< 30 years of age if hispanic or non-white
- For medical or other reasons cannot tolerate a periodontal exam
- If female, pregnant
- Fully edentulous
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Colgate Palmolivecollaborator
Study Sites (1)
Columbia University College of Dental Medicine
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ira B. Lamster, DDS, M.M.Sc.
Columbia University College of Dental Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2012
First Posted
October 22, 2012
Study Start
April 1, 2009
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
August 17, 2021
Record last verified: 2021-08